Last viewed: ADIL


Prices are updated after-hours



nasdaq:ADIL Adial Pharmaceuticals, Inc

ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (37.4% 1m) (629.2% 1y) (0.0% 2d) (-14.2% 3d) (-24.8% 7d) (-79.7% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 9,427,552

http://www.adialpharma.com
Sec Filling | Patents | 4 employees


Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

alcohol use disorder   serotonin-3   msa   treatment  

add to watch list Paper trade email alert is off

Press-releases


Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 123.48% H: 0.0% C: 0.0%

ad04 alcohol publication treatment pharmaceuticals for trial potential
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04
Published: 2024-04-10 (Crawled : 14:30) - biospace.com/
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 123.48% H: 0.0% C: 0.0%

ad04 publication pharmaceuticals trial
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Published: 2024-04-02 (Crawled : 12:30) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -3.23% H: 2.5% C: 2.5%

business year update pharmaceuticals financial results
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Published: 2024-03-02 (Crawled : 00:20) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

million pharmaceuticals
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Published: 2024-02-28 (Crawled : 14:30) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 17.94% H: 178.64% C: 57.28%

patent pharmaceuticals
Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Published: 2024-02-13 (Crawled : 14:00) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 19.33% H: 5.93% C: -8.89%

patent pharmaceuticals
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
Published: 2024-01-18 (Crawled : 13:30) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 3.47% H: 2.86% C: -7.05%


Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate
Published: 2023-12-20 (Crawled : 14:00) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 10.65% H: 5.35% C: -7.48%

payment pharmaceuticals
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
Published: 2023-11-29 (Crawled : 22:00) - adialpharma.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 10.8% H: 13.98% C: -7.2%

nasdaq pharmaceuticals
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 22:00) - globenewswire.com
ADIL | $2.325 3.8% 3.66% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -1.81%

business update pharmaceuticals financial results
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001213900-24-026725 4 2024-03-27 2024-03-25 Buy A 12000 12000
0001213900-24-026724 4 2024-03-27 2024-03-25 Buy A 12000 12000
0001213900-24-026714 4 2024-03-27 2024-03-25 Buy A 25000 25000
0001213900-24-026712 4 2024-03-27 2024-03-25 Buy A 60000 60000


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K twitter stocktwits trandingview |
Technology Services
| 00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M twitter stocktwits trandingview |
Finance
| 22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K twitter stocktwits trandingview |
Retail Trade
| 22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K twitter stocktwits trandingview |
Energy Minerals
| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M twitter stocktwits trandingview |
Health Technology
| 16:30
RMCF | $3.51 -3.7% -3.85% 3.8K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar